SILICON LABORATORIES INC. (SLAB) FY2026 Q2 Statement of Cash Flows

Statement of Cash Flows

2026-04-05 to 2026-07-04

Swipe to see the full flow
SILICON LABORATORIES INC. cash flow reconciliation, Apr 5, 2026 through Jul 4, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Maturities of marketable securities → investing reconciliation: $20,658,000.00Proceeds from capital-related government incentives → investing reconciliation: $4,007,000.00investing reconciliation → Net cash from investing activities: $12,349,000.00investing reconciliation → Purchases of property and equipment: $12,316,000.00Proceeds from the issuance of common stock → financing reconciliation: $7,760,000.00Net cash used in financing activities → financing reconciliation: $18,735,000.00financing reconciliation → Payment of taxes withheld for vested stock awards: $26,495,000.00Net cash used in operating activities → operating reconciliation: $14,512,000.00Stock-based compensation expense → operating reconciliation: $25,649,000.00Depreciation of property and equipment → operating reconciliation: $6,124,000.00Amortization of other intangible assets → operating reconciliation: $2,294,000.00Deferred income taxes → operating reconciliation: $510,000.00operating reconciliation → Net loss: $10,592,000.00operating reconciliation → Inventories: $20,118,000.00operating reconciliation → Prepaid expenses and other assets: $7,616,000.00operating reconciliation → Deferred revenue and returns liability: $4,646,000.00operating reconciliation → Accounts receivable: $2,681,000.00operating reconciliation → Other non-current liabilities: $1,590,000.00operating reconciliation → Accounts payable: $1,336,000.00operating reconciliation → Other current liabilities and income taxes: $510,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $383,089,000.00Net cash from investing activities → Cash sources and uses: $12,349,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $362,191,000.00Cash sources and uses → Net cash used in financing activities: $18,735,000.00Cash sources and uses → Net cash used in operating activities: $14,512,000.00Amortization of other intangible assets: $2,294,000.00Other intangible amortization+$2.29 MNet loss: -$10,592,000.00Net loss−$10.59 MInventories: -$20,118,000.00Inventories−$20.12 MOther current liabilities and income taxes: -$510,000.00Other liabilities & income taxes−$510.00 KDepreciation of property and equipment: $6,124,000.00Depreciation expense+$6.12 MOther non-current liabilities: -$1,590,000.00Other noncurrent liabilities−$1.59 MAccounts payable: -$1,336,000.00Accounts payable−$1.34 MAccounts receivable: -$2,681,000.00Accounts receivable−$2.68 MStock-based compensation expense: $25,649,000.00Stock-based compensation+$25.65 MDeferred revenue and returns liability: -$4,646,000.00Deferred revenue & returns−$4.65 MPrepaid expenses and other assets: -$7,616,000.00Prepaid & other assets−$7.62 MDeferred income taxes: $510,000.00Deferred taxes & credits+$510.00 KNet cash used in operating activities: -$14,512,000.00. Cash required to fund net payments.Operating cash−$14.51 Moperating reconciliation: $49,089,000.00Proceeds from the issuance of common stock: $7,760,000.00Common stock issued+$7.76 MPayment of taxes withheld for vested stock awards: -$26,495,000.00Stock-award tax withholding−$26.50 MNet cash used in financing activities: -$18,735,000.00. Cash required to fund net payments.Financing cash−$18.74 Mfinancing reconciliation: $26,495,000.00Purchases of marketable securities: $0.00Sales of marketable securities: $0.00Maturities of marketable securities: $20,658,000.00Marketable securities maturities+$20.66 MPurchases of property and equipment: -$12,316,000.00PP&E purchases−$12.32 MProceeds from capital-related government incentives: $4,007,000.00Capital incentives received+$4.01 MNet cash from investing activities: $12,349,000.00Investing cash+$12.35 Minvesting reconciliation: $24,665,000.00Cash sources and uses: $395,438,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $383,089,000.00Beginning cash$383.09 MEnding cash: Cash, cash equivalents, and restricted cash: $362,191,000.00Ending cash$362.19 MCASH RECONCILIATIONInvestingflowsFinancingflowsOperatingflowsNet loss −$10.59M − net operating adjustments $3.92M = operating cash −$14.51MFree cash flow−$26.83 MOperating cash − cash spent on PP&ECash flow / Net incomeNot meaningfulOperating cash flow ÷ net incomeNet cash change−$20.90 MEnding cash − beginning cash
Chart details

SILICON LABORATORIES INC. cash flow reconciliation, Apr 5, 2026 through Jul 4, 2026

Cash flows for Apr 5, 2026 through Jul 4, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Apr 4, 2026. Ending cash: Jul 4, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Apr 4, 2026
383,089,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
negative 14,512,000 US dollars. Net cash used.
Net loss
negative 10,592,000 US dollars
Amortization of other intangible assets
2,294,000 US dollars
Inventories
negative 20,118,000 US dollars
Other current liabilities and income taxes
negative 510,000 US dollars
Depreciation of property and equipment
6,124,000 US dollars
Other non-current liabilities
negative 1,590,000 US dollars
Accounts payable
negative 1,336,000 US dollars
Accounts receivable
negative 2,681,000 US dollars
Stock-based compensation expense
25,649,000 US dollars
Deferred revenue and returns liability
negative 4,646,000 US dollars
Prepaid expenses and other assets
negative 7,616,000 US dollars
Deferred income taxes
510,000 US dollars
Investing activities
12,349,000 US dollars. Net cash provided.
Purchases of marketable securities
0 US dollars
Sales of marketable securities
0 US dollars
Maturities of marketable securities
20,658,000 US dollars
Purchases of property and equipment
negative 12,316,000 US dollars
Proceeds from capital-related government incentives
4,007,000 US dollars
Financing activities
negative 18,735,000 US dollars. Net cash used.
Proceeds from the issuance of common stock
7,760,000 US dollars
Payment of taxes withheld for vested stock awards
negative 26,495,000 US dollars
Operating adjustment reconciliation
49,089,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
26,495,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
24,665,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jul 4, 2026
362,191,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
395,438,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 20,898,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
Operating cash flow
negative 14,512,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
12,316,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
negative 26,828,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net loss −$10.59M − net operating adjustments $3.92M = operating cash −$14.51M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 14,512,000 US dollars minus 12,316,000 US dollars equals negative 26,828,000 US dollars.
SILICON LABORATORIES INC. (SLAB) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!